Literature DB >> 19768512

Personalized treatment-the promise of molecular genetics diagnostics.

Saj A Wajed1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19768512     DOI： 10.1007/s11605-009-1016-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  10 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.

Authors:  Qian An; Yong Liu; Yanning Gao; Jinfeng Huang; Xiaoli Fong; Ling Li; Dechao Zhang; Shujun Cheng
Journal:  Cancer Lett       Date:  2002-12-15       Impact factor: 8.679

Review 3.  Oncogenic mechanisms mediated by DNA methylation.

Authors:  P W Laird
Journal:  Mol Med Today       Date:  1997-05

4.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.

Authors:  K Kawakami; J Brabender; R V Lord; S Groshen; B D Greenwald; M J Krasna; J Yin; A S Fleisher; J M Abraham; D G Beer; D Sidransky; H T Huss; T R Demeester; C Eads; P W Laird; D H Ilson; D P Kelsen; D Harpole; M B Moore; K D Danenberg; P V Danenberg; S J Meltzer
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

5.  Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.

Authors:  Michael W Y Chan; Lun W Chan; Nelson L S Tang; Joanna H M Tong; Kwok W Lo; Tin L Lee; Ho Y Cheung; Wai S Wong; Peter S F Chan; Fernand M M Lai; Ka F To
Journal:  Clin Cancer Res       Date:  2002-02       Impact factor: 12.531

6.  Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Authors:  Thierry Lecomte; Anne Berger; Franck Zinzindohoué; Stéphanie Micard; Bruno Landi; Hélène Blons; Philippe Beaune; Paul-Henri Cugnenc; Pierre Laurent-Puig
Journal:  Int J Cancer       Date:  2002-08-10       Impact factor: 7.396

7.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Free DNA in the serum of cancer patients and the effect of therapy.

Authors:  S A Leon; B Shapiro; D M Sklaroff; M J Yaros
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Short-term outcomes following total minimally invasive oesophagectomy.

Authors:  R G Berrisford; S A Wajed; D Sanders; M W M Rucklidge
Journal:  Br J Surg       Date:  2008-05       Impact factor: 6.939
  10 in total
  1 in total

1.  Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.

Authors:  Mariana Campos da Paz; Maria de Fátima M Almeida Santos; Camila M B Santos; Sebastião W da Silva; Lincoln Bernardo de Souza; Emília C D Lima; Renata C Silva; Carolina M Lucci; Paulo César Morais; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2012-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.